Malcolm Finkelman

4.8k total citations
88 papers, 3.6k citations indexed

About

Malcolm Finkelman is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Malcolm Finkelman has authored 88 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 35 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Malcolm Finkelman's work include Antifungal resistance and susceptibility (34 papers), Fungal Infections and Studies (20 papers) and Gut microbiota and health (12 papers). Malcolm Finkelman is often cited by papers focused on Antifungal resistance and susceptibility (34 papers), Fungal Infections and Studies (20 papers) and Gut microbiota and health (12 papers). Malcolm Finkelman collaborates with scholars based in United States, Canada and Thailand. Malcolm Finkelman's co-authors include Luis Ostrosky‐Zeichner, John Rex, Paul A. Ketchum, Barbara D. Alexander, Asada Leelahavanichkul, Richard J. Ridge, Zekaver Odabaşı, Gloria Mattiuzzi, E Estey and Hagop M. Kantarjian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Malcolm Finkelman

86 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malcolm Finkelman United States	33	2.2k	1.9k	803	342	304	88	3.6k
Yoshio Mori Japan	30	1.2k 0.6×	788 0.4×	816 1.0×	294 0.9×	274 0.9×	176	3.5k
Nicasio Mancini Italy	31	1.1k 0.5×	1.2k 0.6×	632 0.8×	458 1.3×	171 0.6×	123	3.3k
Antonio Toniolo Italy	40	918 0.4×	957 0.5×	1.1k 1.4×	688 2.0×	102 0.3×	148	4.6k
Alan M. Sugar United States	37	4.3k 1.9×	4.0k 2.1×	588 0.7×	343 1.0×	380 1.3×	103	6.2k
Charles H. Kirkpatrick United States	34	1.3k 0.6×	1.4k 0.8×	542 0.7×	1.6k 4.6×	357 1.2×	150	4.1k
Didier Hober France	38	2.1k 0.9×	1.1k 0.6×	963 1.2×	1.3k 3.7×	159 0.5×	233	5.5k
Roy T. Steigbigel United States	36	2.2k 1.0×	1.8k 0.9×	621 0.8×	525 1.5×	216 0.7×	75	4.6k
Seth Hetherington United States	27	936 0.4×	668 0.4×	406 0.5×	438 1.3×	144 0.5×	60	2.6k
Neil M. Ampel United States	35	3.1k 1.4×	4.0k 2.1×	276 0.3×	552 1.6×	257 0.8×	156	5.0k
M. P. Dierich Austria	32	1.0k 0.5×	828 0.4×	502 0.6×	1.4k 4.0×	108 0.4×	119	3.3k

Countries citing papers authored by Malcolm Finkelman

Since Specialization

Citations

This map shows the geographic impact of Malcolm Finkelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Finkelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Finkelman more than expected).

Fields of papers citing papers by Malcolm Finkelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Finkelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Finkelman. The network helps show where Malcolm Finkelman may publish in the future.

Co-authorship network of co-authors of Malcolm Finkelman

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Finkelman. A scholar is included among the top collaborators of Malcolm Finkelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Finkelman. Malcolm Finkelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Egger, Matthias, Angela Horvath, Florian Prüller, et al.. (2023). Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study. Liver International. 43(9). 1975–1983. 10 indexed citations

Hiengrach, Pratsanee, Peerapat Visitchanakun, Malcolm Finkelman, Wiwat Chancharoenthana, & Asada Leelahavanichkul. (2022). More Prominent Inflammatory Response to Pachyman than to Whole-Glucan Particle and Oat-β-Glucans in Dextran Sulfate-Induced Mucositis Mice and Mouse Injection through Proinflammatory Macrophages. International Journal of Molecular Sciences. 23(7). 4026–4026. 18 indexed citations

Ouyang, Jing, Stéphane Isnard, John Lin, et al.. (2020). Daily variations of gut microbial translocation markers in ART-treated HIV-infected people. AIDS Research and Therapy. 17(1). 15–15. 12 indexed citations

Hoenigl, Martin, John Lin, Malcolm Finkelman, et al.. (2020). Glucan rich nutrition does not increase gut translocation of beta‐glucan. Mycoses. 64(1). 24–29. 17 indexed citations

Melo, Analy Salles de Azevedo, Daniel Wagner de Castro Lima Santos, Anderson Messias Rodrigues, et al.. (2019). Evaluation of (1 → 3)‐β‐D‐glucan assay for diagnosing paracoccidioidomycosis. Mycoses. 63(1). 38–42. 10 indexed citations

Panpetch, Wimonrat, Naraporn Somboonna, Pratsanee Hiengrach, et al.. (2019). Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium. PLoS ONE. 14(1). e0210798–e0210798. 56 indexed citations

Worasilchai, Navaporn, Nitipong Permpalung, Pakawat Chongsathidkiet, et al.. (2018). Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β- d -Glucan in Vascular Pythiosis. Journal of Clinical Microbiology. 56(8). 16 indexed citations

Panpetch, Wimonrat, Naraporn Somboonna, Jiraphorn Issara-Amphorn, et al.. (2017). Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1→3)-β-D-glucan. PLoS ONE. 12(7). e0181439–e0181439. 58 indexed citations

Wong, Jonathan, et al.. (2016). Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan. PLoS ONE. 11(10). e0164978–e0164978. 18 indexed citations

10.

Leelahavanichkul, Asada, Navaporn Worasilchai, Poorichaya Somparn, et al.. (2016). Gastrointestinal Leakage Detected by Serum (1→3)-β-D-Glucan in Mouse Models and a Pilot Study in Patients with Sepsis. Shock. 46(5). 506–518. 72 indexed citations

11.

Hoenigl, Martin, Michelli F. Oliveira, Josué Pérez‐Santiago, et al.. (2016). (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy. Medicine. 95(11). e3162–e3162. 28 indexed citations

12.

Shupp, Jeffrey W., Rūta Petraitienė, Amín D. Jaskille, et al.. (2011). Early serum (1→3)‐β‐D‐glucan levels in patients with burn injury. Mycoses. 55(3). 224–227. 10 indexed citations

13.

Acosta, Joshi, M. Catalán, Juan Carlos Montejo, et al.. (2011). Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. European Journal of Clinical Microbiology & Infectious Diseases. 31(5). 721–731. 37 indexed citations

14.

Hale, Thomas W., et al.. (2009). The Absence of Candida albicans in Milk Samples of Women with Clinical Symptoms of Ductal Candidiasis. Breastfeeding Medicine. 4(2). 57–61. 31 indexed citations

15.

Marty, Francisco M., et al.. (2006). Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous Antimicrobials. Antimicrobial Agents and Chemotherapy. 50(10). 3450–3453. 115 indexed citations

16.

Ostrosky‐Zeichner, Luis & Malcolm Finkelman. (2006). Reply to Upton et al. Clinical Infectious Diseases. 42(7). 1056–1056. 1 indexed citations

17.

Ostrosky‐Zeichner, Luis, Barbara D. Alexander, Daniel H. Kett, et al.. (2005). Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans. Clinical Infectious Diseases. 41(5). 654–659. 496 indexed citations

18.

Eller, Monique Renon, et al.. (2002). False positive endotoxin results in a DC product caused by (1→3)-β–d-glucans acquired from a sterilizing cellulose filter. Cytotherapy. 4(6). 557–559. 10 indexed citations

19.

Finkelman, Malcolm, et al.. (2000). Prostatic secretory protein (PSP94) expression in human female reproductive tissues, breast and in endometrial cancer cell lines. Journal of Endocrinology. 165(2). 425–433. 22 indexed citations

20.

Yang, Jingping, Malcolm Finkelman, & Michael W. Clarke. (1998). DETECTION OF PSP94 AND ITS SPECIFIC BINDING SITES IN THE PROSTATE ADENOCARCINOMA CELL LINE LNCaP. The Journal of Urology. 2240–2244. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact